Health
Gedeon Richter 9-Month Sales In Romania Flat On Year At EUR97M
Hungarian drug maker Gedeon Richter Tuesday said its Romanian sales were flat in euros during the first nine months, at EUR97 million, with the wholesale and retail activity slightly higher.
Zentiva Romania To Invest EUR9 Million To Boost Output By 50% In Five Years
Pharmaceutical company Zentiva Romania (SCD.RO), part of the Sanofi group, plans to increase its output by 50% over the next five years and will invest EUR9 million in its Romanian plant.
Bucharest Authorities Want To Expand Colentina Hospital For EUR50M
The Bucharest Hospitals and Medical Service Administration wants to contract design and construction services to extend the Colentina clinical hospital.
Antitrust Authorities To Soon Finish Investigations Targeting Food And Electronics Retailers, Drug Distributors
Bogdan Chiritoiu, president of the Competition Council, announced that the institution will next year conclude an investigation into agreements between retailers such as Metro, Billa and Sel...
Ropharma To Acquire At Least 10 Independent Pharmacies In 2013
Romanian pharmaceutical company Ropharma (RPH.RO), with operations in retail, distribution and production of medicine drugs, expects a turnover increase by at least 10% in 2012, said Mihai M...
Private Healthcare Sector Sees EUR100M Investment In Nine Months
The private healthcare service sector attracted more than EUR100 million investments in the first nine months, reveals a ZF analysis based on data provided by companies in the industry. The...
Ropharma Profit Falls 40% In January-September
Romanian generic drugs wholesaler Ropharma Brasov (RPH.RO) Wednesday said its profit fell 40% to 5.2 million lei (EUR1.2 million) in the first nine months of 2012, from RON8.6 million in the...
Farmaceutica Remedia Sales Rise 19% In January-September
Romanian pharmaceuticals supplier Farmaceutica Remedia Deva (RMAH.RO) Wednesday said its sales rose 19% to 171.4 million lei (EUR38.6 million) in the first nine months, from RON144.6 million...
Cantacuzino Institute To Resume Vaccine Production Within 12 To 18 Months
Romania’s Cantacuzino Institute will resume its production of vaccines, including seasonal flu shots, within 12 to 18 months since the beginning of talks on its reorganization, Health Minist...